Evidence map›Paper›PMID 40524255›Full record

ArticleDisaster medicine and public health preparedness2025

The Impact of the COVID-19 Pandemic on the Care of Pregnant Women with a Focus on Those who Use Substances: Lessons for the Future.

Caitlin Green, Amy Board, Claudia Squire, Elizabeth T Adams, Shin Y Kim, Jill A Brown, Peyton Williams, Raahina Malik, Kara Polen, Suzanne M Gilboa and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Disaster medicine and public health preparedness, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Caitlin GreenDivision of Birth Defects and Infant Disorders, https://ror.org/042twtr12Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.ORCID 0000-0002-9191-4187
Amy BoardDivision of Birth Defects and Infant Disorders, https://ror.org/042twtr12Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Claudia SquireResearch Triangle Institute (RTI) International, Research Triangle Park, NC, USA.
Elizabeth T AdamsResearch Triangle Institute (RTI) International, Research Triangle Park, NC, USA.
Shin Y KimDivision of Birth Defects and Infant Disorders, https://ror.org/042twtr12Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Jill A BrownResearch Triangle Institute (RTI) International, Research Triangle Park, NC, USA.
Peyton WilliamsResearch Triangle Institute (RTI) International, Research Triangle Park, NC, USA.
Raahina MalikResearch Triangle Institute (RTI) International, Research Triangle Park, NC, USA.
Kara PolenDivision of Birth Defects and Infant Disorders, https://ror.org/042twtr12Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Suzanne M GilboaDivision of Birth Defects and Infant Disorders, https://ror.org/042twtr12Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Kathryn MieleDivision of Birth Defects and Infant Disorders, https://ror.org/042twtr12Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectivesAbout 13% of pregnant women with substance use disorder (SUD) receive treatment and many may encounter challenges in accessing perinatal care, making it critical for this population to receive uninterrupted care during a global pandemic.

methodsFrom October 2021-January 2022, we conducted an online survey of pregnant and postpartum women and interviews with clinicians who provide care to this population. The survey was administered to pregnant and postpartum women who used substances or received SUD treatment during the COVID-19 pandemic.

resultsTwo hundred and ten respondents completed the survey. All respondents experienced pandemic-related barriers to routine health care services, including delays in prenatal care and SUD treatment. Disruptions in treatment were due to patient factors (38.2% canceled an appointment) and clinic factors (25.5% had a clinic cancel their appointment). Respondents were generally satisfied with telehealth (

conclusionsAlthough strategies were employed to mitigate barriers in care during COVID-19, pregnant and postpartum women who used substances still experienced barriers in receiving consistent care. Telehealth may be a useful adjunct to enhance care access for pregnant and postpartum women during public health crises.

Indexed as

COVID-19Pregnant PeopleSubstance-Related DisordersAdultFemaleHealth Services AccessibilityHumansPandemicsPregnancySurveys and QuestionnairesTelemedicineCOVID-19emergency preparednesshealth care facilities and servicespregnancysubstance usetreatmentvulnerable populations

Identifiers

PMID40524255
PMCPMC12366436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.